Literature DB >> 16857267

Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders.

C Raymond Lake1, Nathaniel Hurwitz.   

Abstract

Schizoaffective disorder (SA D/O), introduced in 1933 by Dr. Jacob Kasanin, represented a first, modest change in our concept about the diagnoses of psychotic patients away from the beliefs of E. Bleuler, i.e., that hallucinations and delusions define schizophrenia, and toward the recognition of a significant role for mood disorders. SA D/O established a connection between schizophrenia and mood disorders, traditionally considered mutually exclusive, a connection that has strengthened progressively toward the diagnostic unity of all three disorders. A basic tenet of medicine holds that if discrepant symptoms can be explained by one disease instead of two or more, it is likely there is only one disease. The scientific justification for SA D/O and schizophrenia as disorders distinct from a psychotic mood disorder has been questioned. The "schizo" prefix in SA D/O rests upon the presumption that the diagnostic symptoms for schizophrenia are disease specific. They are not, since patients with severe mood disorders can evince any or all of the "schizophrenic" symptoms. "Schizophrenic" symptoms mean "psychotic" and not any specific disease. These data and a very low interrater reliability for SA D/O suggest that the concepts of SA D/O and schizophrenia as valid diagnoses are flawed. Clinically SA D/O remains popular because it encompasses both schizophrenia and psychotic mood disorder when there is a diagnostic question. We present a review of the literature in table form based on an assignment of each article assigned to one of five categories that describe the possible relationships between SA D/O, schizophrenia and psychotic mood disorders. We conclude that the data overall are compatible with the hypothesis that a single disease, a mood disorder, with a broad spectrum of severity, rather than three different disorders, accounts for the functional psychoses.

Entities:  

Mesh:

Year:  2006        PMID: 16857267     DOI: 10.1016/j.psychres.2005.08.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  19 in total

1.  At the edge of the bipolar spectrum: primacy of affective over psychotic symptoms or vice versa?

Authors:  Heinz Grunze
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

2.  Memoir and the Diagnosis of Schizophrenia: Reflections on The Center Cannot Hold, Me, Myself, and Them, and the 'Crumbling Twin Pillars' of Kraepelinian Psychiatry.

Authors:  Angela M Woods
Journal:  Ment Health Rev (Brighton)       Date:  2011

Review 3.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

4.  Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder.

Authors:  Stephanie A Rolin; Kelly A Aschbrenner; Karen L Whiteman; Emily Scherer; Stephen J Bartels
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-03       Impact factor: 4.105

5.  Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type.

Authors:  Elena Estrada; Sarah M Hartz; Jeffrey Tran; Donald M Hilty; Pamela Sklar; Jordan W Smoller; Michele T Pato; Carlos N Pato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-10-15       Impact factor: 3.568

Review 6.  Problems in the boundaries of bipolar disorders.

Authors:  Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

7.  The schizophrenias, the neuroses and the covered wagon; a critical review.

Authors:  C Raymond Lake; Nathaniel Hurwitz
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

8.  Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.

Authors:  Matthew J Smith; Deanna M Barch; John G Csernansky
Journal:  Schizophr Res       Date:  2008-09-10       Impact factor: 4.939

9.  Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Authors:  S Kristian Hill; James L Reilly; Richard S E Keefe; James M Gold; Jeffrey R Bishop; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

10.  Combination therapy or monotherapy for the depressed type of schizoaffective disorder.

Authors:  Lubomira Izáková; Ivan Andre; Angelos Halaris
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.